Mucosal immune response after the booster dose of the BNT162b2 COVID-19 vaccine

BACKGROUND: To date, only a few studies reported data regarding the development of mucosal immune response after the BNT162b2-booster vaccination. METHODS: Samples of both serum and saliva of 50 healthcare workers were collected at the day of the booster dose (T3) and after two weeks (T4). Anti-S1-p...

Descripción completa

Detalles Bibliográficos
Autores principales: Azzi, Lorenzo, Dalla Gasperina, Daniela, Veronesi, Giovanni, Shallak, Mariam, Maurino, Vittorio, Baj, Andreina, Gianfagna, Francesco, Cavallo, Pierpaolo, Dentali, Francesco, Tettamanti, Lucia, Maggi, Fabrizio, Maffioli, Lorenzo Stefano, Tagliabue, Angelo, Accolla, Roberto Sergio, Forlani, Greta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9828819/
https://www.ncbi.nlm.nih.gov/pubmed/36628844
http://dx.doi.org/10.1016/j.ebiom.2022.104435

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9828819/
https://www.ncbi.nlm.nih.gov/pubmed/36628844
http://dx.doi.org/10.1016/j.ebiom.2022.104435

Ejemplares similares